The International Normalized Ratio calibrated for rivaroxaban has the potential to normalize prothrombin time results for rivaroxaban-treated patients: results of an in vitro study

被引：99
|
作者：
Tripodi, A. [1 ,2 ]
Chantarangkul, V. [1 ,2 ]
Guinet, C.
Samama, M. M. [3 ]
机构：
[1] Osped Maggiore, Policlin Fdn, IRCCS Ca Granda,Dept Internal Med, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ctr, I-20122 Milan, Italy
[2] Univ Milan, Milan, Italy
[3] Hotel Dieu Univ Hosp, Paris, France
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2011年 / 9卷 / 01期
关键词：
FACTOR XA INHIBITOR;
D O I：
10.1111/j.1538-7836.2010.04106.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：227 / 228
页数：2
相关论文
共 25 条
  • [1] Inaccuracy of Point-of-Care International Normalized Ratio in Rivaroxaban-Treated Patients
    Baruch, Lawrence
    Sherman, Olga
    ANNALS OF PHARMACOTHERAPY, 2013, 47 (09) : 1210 - 1212
  • [2] Prothrombin Time-International Normalized Ratio Predicts the Outcome of Atrial Fibrillation Patients Taking Rivaroxaban
    Chao, Tze-Fan
    Chan, Yi-Hsin
    Tsai, Pei-Chien
    Lee, Hsin-Fu
    Chang, Shang-Hung
    Kuo, Chi-Tai
    Lip, Gregory Y. H.
    Chen, Shih-Ann
    Yeh, Yung-Hsin
    BIOMEDICINES, 2022, 10 (12)
  • [3] The prothrombin time does not predict the risk of recurrent venous thromboembolism or major bleeding in rivaroxaban-treated patients
    ten Cate, Hugo
    Lensing, Anthonie W. A.
    Weitz, Jeffrey I.
    Middeldorp, Saskia
    Beyer-Westendorf, Jan
    Kubitza, Dagmar
    Brighton, Timothey
    Raskob, Gary E.
    Mismetti, Patrick
    Prandoni, Paolo
    Gebel, Martin
    Prins, Martin H.
    THROMBOSIS RESEARCH, 2018, 170 : 75 - 83
  • [4] International Normalized Ratio as a Screening Test for Assessment of Anticoagulant Activity for Patients Treated With Rivaroxaban or Apixaban: A Pilot Study
    Ofek, Fanny
    Barchel, Dana
    Perets, Nofar
    Ziv-Baran, Tomer
    Mahajna, Ahmad
    Filipovich-Rimon, Talia
    Garach-Jehoshua, Osnat
    Berlin, Maya
    Berkovitch, Matitiahu
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [5] Variations of prothrombin time and international normalized ratio in patients treated with warfarin
    Ho, CH
    Lin, MW
    You, JY
    Chen, CC
    Yu, TJ
    THROMBOSIS RESEARCH, 2002, 107 (05) : 277 - 280
  • [6] THE NORMALIZED PROTHROMBIN RATIO (NPR) - A POSSIBLE ALTERNATIVE TO THE INTERNATIONAL NORMALIZED RATIO (INR) SYSTEM FOR STANDARDIZING PROTHROMBIN TIME (PT) RESULTS
    EBERT, RF
    NG, VL
    STEAD, AG
    BLOOD, 1994, 84 (10) : A64 - A64
  • [7] A SIMPLE METHOD FOR THE DERIVATION OF THE INTERNATIONAL NORMALIZED RATIO FOR THE REPORTING OF PROTHROMBIN TIME RESULTS
    HABIBZADEH, F
    YADOLLAHIE, M
    AMERICAN JOURNAL OF HEMATOLOGY, 1995, 50 (04) : 283 - 287
  • [8] The international normalized ratio calibrated for cirrhosis (INRliver) normalizes prothrombin time results for model for end-stage liver disease calculation
    Tripodi, Armando
    Chantarangkul, Veena
    Primignani, Massimo
    Fabris, Federica
    Dell'Era, Alessandra
    Sei, Cinzia
    Mannucci, Pier Mannuccio
    HEPATOLOGY, 2007, 46 (02) : 520 - 527
  • [9] Reporting prothrombin time results as international normalized ratios for patients with chronic liver disease
    Tripodi, A.
    Baglin, T.
    Robert, A.
    Kitchen, S.
    Lisman, T.
    Trotter, J. F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2010, 8 (06) : 1410 - 1412
  • [10] VARIATIONS IN PROTHROMBIN TIME AND INTERNATIONAL NORMALIZED RATIO OVER 24 HOURS IN WARFARIN-TREATED PATIENTS
    BLESKE, BE
    WELAGE, LS
    WARREN, EW
    BROWN, MB
    SHEA, MJ
    PHARMACOTHERAPY, 1995, 15 (06): : 709 - 712
123